Related Party Transactions - Licensing Agreement with Equity Method Investee (Details) - USD ($)	12 Months Ended			24 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2024	Oct. 31, 2020
Angel Pharmaceuticals, Ltd
Related Party Transaction [Line Items]
Equity ownership interest	49.70%			49.70%	53.20%
Equity Method Investee | Intellectual Property Licensing Agreement
Related Party Transaction [Line Items]
Internal personnel costs billed to subsidiary			$ 100,000	$ 0
Third-party costs billed to subsidiary	$ 0	$ 100,000	1,300,000
Clinical drug supply costs			500,000
Clinical drug supply, passthrough costs		100,000	800,000
Amounts reimbursed to subsidiary for drug supply and research services	$ 0	$ 200,000	$ 200,000